These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19352366)

  • 21. The power of genomics to transform the biotechnology industry.
    Haseltine WA
    Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimizing the impact of genomics on drug discovery and development.
    Crooke ST
    Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
    [No Abstract]   [Full Text] [Related]  

  • 23. Engineered single chain antibody fragments for radioimmunotherapy.
    Huhalov A; Chester KA
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):279-88. PubMed ID: 15640791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment on "The economics of follow-on drug research and development: trends in entry rates and the timing of development".
    Hollis A
    Pharmacoeconomics; 2005; 23(12):1187-92; discussion 1193-202. PubMed ID: 16336012
    [No Abstract]   [Full Text] [Related]  

  • 25. Bristol-Myers Squibb locks into novel autoimmune strategy.
    Garber K
    Nat Biotechnol; 2016 Jun; 34(6):577-9. PubMed ID: 27281396
    [No Abstract]   [Full Text] [Related]  

  • 26. Natural Product-Based Drug Discovery.
    Li R
    Med Res Rev; 2016 Jan; 36(1):3. PubMed ID: 26662060
    [No Abstract]   [Full Text] [Related]  

  • 27. MipTec: breaking down the silos of information.
    Yates I
    Drug Discov Today; 2004 Oct; 9(20):871-3. PubMed ID: 15475319
    [No Abstract]   [Full Text] [Related]  

  • 28. An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser.
    Valenzano KJ
    Assay Drug Dev Technol; 2011 Jun; 9(3):191-7. PubMed ID: 21612548
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant polyclonal antibodies: therapeutic antibody technologies come full circle.
    Haurum J; Bregenholt S
    IDrugs; 2005 May; 8(5):404-9. PubMed ID: 15883923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interview with Richard M. Eglen, Ph.D.
    Eglen RM
    Assay Drug Dev Technol; 2006 Oct; 4(5):503-9. PubMed ID: 17115921
    [No Abstract]   [Full Text] [Related]  

  • 32. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates.
    Roughley SD; Jordan AM
    J Med Chem; 2011 May; 54(10):3451-79. PubMed ID: 21504168
    [No Abstract]   [Full Text] [Related]  

  • 33. Where will we get the next generation of medicinal chemists?
    Allen D
    Drug Discov Today; 2016 May; 21(5):704-6. PubMed ID: 27131748
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 35. Natural products in drug discovery: present status and perspectives.
    Molinari G
    Adv Exp Med Biol; 2009; 655():13-27. PubMed ID: 20047031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical genomics versus orthodox drug development.
    Szymkowski DE
    Drug Discov Today; 2003 Feb; 8(4):157-9. PubMed ID: 12581708
    [No Abstract]   [Full Text] [Related]  

  • 37. Noordwijkerhout-Camerino--15th Symposium. Trends in drug research.
    Triggle DJ
    IDrugs; 2005 Jul; 8(7):563-6. PubMed ID: 15973564
    [No Abstract]   [Full Text] [Related]  

  • 38. Carlo Incerti.
    Incerti C
    Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428
    [No Abstract]   [Full Text] [Related]  

  • 39. Toward biosimilar monoclonal antibodies.
    Schneider CK; Kalinke U
    Nat Biotechnol; 2008 Sep; 26(9):985-90. PubMed ID: 18779806
    [No Abstract]   [Full Text] [Related]  

  • 40. Back to the future: driving innovation in drug development.
    Wagner JA
    Clin Pharmacol Ther; 2008 Feb; 83(2):199-202. PubMed ID: 18202681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.